20358611000001109: Caprelsa 100mg tablets (Sanofi Genzyme) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Caprelsa 100mg tablets (Sanofi Genzyme)
\UK product\Virtual medicinal product\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\UK product\Virtual therapeutic moiety\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\UK product\Trade family\Caprelsa\Caprelsa 100mg tablets (Sanofi Genzyme)

\Medicinal product\Medicinal product categorized by disposition\Product containing angiogenesis inhibitor\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing piperidine derivative\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing vandetanib\Vandetanib\Vandetanib 100mg tablets\Caprelsa 100mg tablets (Sanofi Genzyme)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1911161000001118 Caprelsa 100mg tablets (Sanofi Genzyme) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1911171000001111 Caprelsa 100mg tablets (Sanofi Genzyme) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Caprelsa 100mg tablets (Sanofi Genzyme)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	false	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Is a	Vandetanib 100mg tablets	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has active ingredient	Vandetanib	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has specific active ingredient	Vandetanib	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Is a	Caprelsa	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets	Has AMP	True	Caprelsa 100mg tablets (Sanofi Genzyme)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1911161000001118	Caprelsa 100mg tablets (Sanofi Genzyme)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1911171000001111	Caprelsa 100mg tablets (Sanofi Genzyme) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module